Growth Metrics

BioNTech SE (BNTX) Cash from Financing Activities (2018 - 2025)

BioNTech SE's Cash from Financing Activities history spans 8 years, with the latest figure at -$16.6 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 113.39% to -$16.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$59.7 million, a 20.26% decrease, with the full-year FY2025 number at -$59.8 million, down 21.85% from a year prior.
  • Cash from Financing Activities hit -$16.6 million in Q4 2025 for BioNTech SE, down from -$13.4 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BNTX hit a ceiling of $184.1 million in Q2 2021 and a floor of -$833.9 million in Q2 2022.
  • Historically, Cash from Financing Activities has averaged -$112.2 million across 5 years, with a median of -$14.2 million in 2023.
  • The widest YoY moves for Cash from Financing Activities: up 1660329323.39% in 2022, down 118001159.55% in 2022.
  • Tracing BNTX's Cash from Financing Activities over 5 years: stood at $55.94 in 2021, then tumbled by 118001159.55% to -$66.0 million in 2022, then skyrocketed by 78.97% to -$13.9 million in 2023, then surged by 43.8% to -$7.8 million in 2024, then tumbled by 113.39% to -$16.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for BNTX at -$16.6 million in Q4 2025, -$13.4 million in Q3 2025, and -$15.1 million in Q2 2025.